Tuberculosis Research and Treatment / 2014 / Article / Tab 3

Research Article

Profile, Outcomes, and Determinants of Unsuccessful Tuberculosis Treatment Outcomes among HIV-Infected Tuberculosis Patients in a Nigerian State

Table 3

Predictors of unsuccessful tuberculosis treatment outcomes among 109 urban TB/HIV patients in Ebonyi State, Nigeria, 2011-2012.

CharacteristicsSuccessful outcome
(%)
Unsuccessful outcome
(%)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Adjusted value

Age (years)
 ≤4063 (78.8)17 (21.2)11
 >4020 (69.0)9 (31.0)1.7 (0.6–4.3)1.4 (0.5–3.8)0.56
Gender
 Female40 (76.9)12 (23.1)11
 Male43 (75.4)14 (24.6)1.08 (0.5–2.6)1.3 (0.5–3.5)0.56
Facility
 Public21 (67.7)10 (32.3)1.9 (0.7–4.7)4.5 (1.2–16.7)0.023
 Private62 (79.5)16 (20.5)11
Treatment category
 New78 (76.5)24 (23.5)11
 Previously treated5 (71.4)2 (28.6)1.3 (0.2–7.1)1.8 (0.3–11.1)0.54
Type of TB
 Pulmonary80 (75.5)26 (24.5)
 Extrapulmonary3 (100.0)0.0
Anti-TB regimen
 Regimen 150 (74.6)17 (25.4)1.3 (0.5–3.1)1.2 (0.4–3.7)0.74
 Regimen 233 (78.6)9 (21.4)11
Received ART
 Yes31 (83.8)6 (16.2)11
 No52 (72.2)20 (27.8)2.0 (0.7–5.5)7.0 (1.3–36.8)0.021
Received CPT
 Yes45 (77.6)13 (22.4)11
 No38 (74.5)13 (25.5)1.2 (0.5–2.9)1.4 (0.5–4.4)0.53

Regimen 1: 2RHZE/6EH; regimen 2: 2RHZE/4RH (R: rifampicin, H: isoniazid, Z: pyrazinamide, and E: ethambutol); OR: odds ratio; ART: antiretroviral therapy; TB: tuberculosis; HIV: human immunodeficiency virus; CPT: cotrimoxazole preventive therapy.